Anthrax | sciencenewsnet.in

Breaking News

ADDMAN Secures Qualification Project for CuNi Submarine Fittings with the US Navy

It’s easier now to treat opioid addiction with medication — but use has changed little

Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

A new report from the American Lung Association shows nearly 40% of people across the U.S. are living in areas that are heavily polluted.

Five facilities at Argonne where climate solutions are front and center

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

For Immigrants to Canada, Risk of MS Increases with Proportion of Life Spent There

Sweet potato quality analysis is enhanced with hyperspectral imaging and AI

The Medical Minute: Supervised exercise therapy eases symptoms of peripheral artery disease

Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients

25 Apr, 2024

GW Wins Contract to Develop Antidote-Bearing Organisms to Protect Against Biological, Chemical Threats

September 10, 2021 sarah JonasFeature

The George Washington University has been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.